After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
Xenon Pharmaceuticals Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of Xenon Pharmaceuticals Inc is $3.21B. A total of 0.83 million shares were traded on the day, compared to an average of 827.78K shares.
In the most recent transaction, MORTIMER IAN sold 25,000 shares of XENE for 40.16 per share on Oct 01 ’25. After the transaction, the PRESIDENT, CEO & INTERIM CFO now owns 31,302 company shares. In a previous transaction on Oct 01 ’25, IAN MORTIMER bought 25,000 shares at 40.16 per share.
Among the insiders who bought shares, SHERRY AULIN acquired of 2,548 shares on Sep 19 ’25 at a per-share price of $37.08. In another insider transaction, GANNON STEVEN sold 3 shares at $30.48 per share on Jun 05 ’25. Company shares held by the Director now total 7,141.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, XENE has a high of $46.00 and a low of $26.74.
As of this writing, XENE has an earnings estimate of -$1.16 per share for the current quarter. EPS was calculated based on a consensus of 13.0 estimates, with a high estimate of -$0.99 per share and a lower estimate of -$1.27. The company reported an EPS of -$0.81 in the last quarter
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. XENE’s latest balance sheet shows that the firm has $551.77M in Cash & Short Term Investments as of fiscal 2021. There were $8.26M in debt and $14.32M in liabilities at the time. Its Book Value Per Share was $8.24, while its Total Shareholder’s Equity was $550.03M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for XENE is Buy with a score of 4.81.
